Preferences
Related Series
Related Segments
Related Articles


Global (Non-US) EMR Market Share 2022
The Impact of the Pandemic’s Second Year
Current Time Inside Cache Tag Helper: 6/1/2023 12:32:09 PM and Model.reportId = 2034
2021 was an active year for EMR purchasing despite the continued impact of the COVID-19 pandemic. Over 150 provider organizations outside the US signed an EMR contract in 2021, covering 31 different vendors and impacting over 430 hospitals. While total decisions were lower in 2021 than in any other of the last five years, the number of beds impacted was above average thanks to a number of larger organizations making EMR purchase decisions. Europe remains the most active region, though Africa and Asia both saw increased purchase energy from 2020. The pandemic continues to hinder EMR decisions most in Oceania and Latin America (especially Spanish-speaking countries).if you don't have a login, getting started is easy.
Key Findings:
- Health Insights, Dedalus, and Cerner Lead Multiregional Vendors in 2021
- Most-Selected Regional Vendors Are Softway Medical, SIB, and CGM in Europe and MV in Latin America
- Europe: Softway Medical and SIB Bolstered by GHT Decisions; Dedalus Active in DACHL, Cerner in the UK
- Middle East/Africa: Health Insights Selected in Large Egypt Decision; InterSystems and IQVIA Lead Out in the Middle East
- Latin America: In Slowing Brazil Market, MV and Philips Lead; MEDITECH Makes Gains in the Caribbean
- Asia/Oceania: ezCaretech Branches Out as Asia Rebounds; Oceania Quiet
- Canada: Two Large MEDITECH Migrations to Expanse; One Conglomerate Chooses Cerner

Writer
Amanda Wind Smith

Designer
Jess Wallace-Simpson

Project Manager
Jill Knapp
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.